Relypsa Inc (RLYP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RLYP | SUPN | TSHA | ||
| Company | Relypsa Inc | Supernus Pharm | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 31.98 | 30.74 | 2.65 | ||
| High | 31.98 | 30.91 | 2.75 | ||
| Low | 31.98 | 30.00 | 2.54 | ||
| Last | 31.98 | 30.83 | 2.57 | ||
| Change | -0.01 | +0.56 | -0.01 | ||
| % Change | -0.03% | +1.85% | -0.39% | ||
| Volume | 107 | 362,400 | 1,053,300 | ||
| 20-Day Average Volume | 1,769,415 | 362,015 | 1,851,930 | ||
| Previous Close | 31.99 | 30.27 | 2.58 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.95 | 30.26 | 2.59 | ||
| 20-Day Raw Stochastic | 62.50% | 49.22% | 33.86% | ||
| 20-Day Relative Strength | 76.83% | 50.06% | 50.86% | ||
| Weighted Alpha | +3.30 | -9.03 | +18.27 | ||
| Today's Opinion | N/A | 56% Buy | 40% Buy | ||
| Previous Opinion | N/A | 40% Buy | 40% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 08/25/16 | +2.53% since 04/26/24 | +7.53% since 04/26/24 | ||
| Low | 31.95 on 08/29/16 | 29.79 on 05/02/24 | 2.35 on 05/01/24 | ||
| High | 32.04 on 08/31/16 | 31.27 on 04/29/24 | 2.75 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | +0.47% since 08/01/16 | -8.92% since 04/03/24 | -5.51% since 04/03/24 | ||
| Low | 31.83 on 08/02/16 | 28.63 on 04/18/24 | 2.14 on 04/19/24 | ||
| High | 32.04 on 08/31/16 | 34.49 on 04/04/24 | 3.40 on 04/10/24 | ||
| 3-Month | |||||
| %Chg | +61.03% since 06/01/16 | +11.42% since 02/02/24 | +70.20% since 02/02/24 | ||
| Low | 15.73 on 06/27/16 | 26.27 on 02/28/24 | 1.41 on 02/14/24 | ||
| High | 32.12 on 07/27/16 | 35.44 on 03/21/24 | 3.55 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | +137.59% since 03/01/16 | +25.94% since 11/03/23 | +3.63% since 11/03/23 | ||
| Low | 11.60 on 03/16/16 | 23.05 on 11/07/23 | 1.27 on 11/14/23 | ||
| High | 32.12 on 07/27/16 | 35.44 on 03/21/24 | 3.55 on 03/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,434,910 | 1,694,848 | 480,636 | ||
| Shares Outstanding, K | 44,840 | 54,974 | 187,018 | ||
| Annual Sales | 18,550,000 | 607,520,000 | 15,450,000 | ||
| Annual Net Income | -178,720,000 | 1,320,000 | -111,570,000 | ||
| Last Quarter Sales | 5,220,000 | 164,310,000 | 3,600,000 | ||
| Last Quarter Net Income | -83,620,000 | 1,170,000 | 47,740,000 | ||
| 60-Month Beta | 2.19 | 1.01 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 05/04/16 | 0.02 on 02/27/24 | 0.35 on 03/19/24 | ||
| Latest Earnings Date | 08/11/16 | 05/08/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||